West Pharmaceutical Services' stock has been sluggish, trading near its 52-week low, with analysts downgrading estimates and ...

Shares of West Pharmaceutical Services Inc. WST shed 2.05% to $290.42 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.96% to ...

On Wednesday, West Pharmaceutical Services Inc. (WST) stock saw a modest uptick, ending the day at $286.52 which represents a slight increase of $0.04 or 0.01% from the prior close of $286.48. The ...

West Pharmaceutical Services, Inc. (WST) is a leading global manufacturer specializing in the design and production of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

After hours: 8 October at 17:30 GMT-4 ...

The Food and Drug Administration is warning about a shortage of three types of IV fluid made at the Baxter pharmaceutical ...

Revenue: $4.2 billion, up 11% in local currency terms. Adjusted EBITDA: $1.2 billion, up 4%. Non-GAAP EPS: $0.61, up 9%. GAAP Operating Loss: $5 million, improved from a $654 million loss last year.